ADAS 3D
K240791Adas3D Medical S.L · cleared 2024-09-09 · product code QIH · Radiology
Premarket evidence — what FDA accepted
source quote (p.6)
“ADAS 3D is a stand-alone software tool intended to be used for post-processing cardiovascular enhanced Magnetic Resonance (MR) images and Computed Tomography Angiography (CTA) images that are formatted in the Digital Imaging and Communication in Medicine (DICOM) standard.”
source quote (p.6)
“Additionally, ADAS 3D uses the following machine-learning-based features: Standard Initialization of the LV, LA, and Aorta from CTA Standard Initialization of the Coronary Arteries from CTA Standard Initialization of the LA from CTA Standard Initialization of the LV from 2D LGE-MRI and Automatic Slice Alignment Standard Initialization of the LV from 3D LGE-MRI Standard Initialization of the LA from 3D LGE-MRI”
Validation studies (2)
Retrospective clinical
n=796 images
Retrospective clinical
n=665 cases
endpoints: MSD: Mean Surface Distance; HD: Hausdorff Distance; MDS: Mean Difference in Shifts; APD: Average Perpendicular Distance; DC: Dice Metric; CA: Color agreement; CD1: Color disagreement by one color; CD2: Color disagreement by two colors or more
Reported performance (0 observations)
FDA source did not state a quantitative performance metric — non-reporting is itself the signal.
Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.
Predicate network
Postmarket — what happened after clearance
Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.
Reimbursement — how devices like this got paid
Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).